Skip to main content
logo
NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
3.730
-0.490 (-11.61%)
At close: Sep 5, 2025, 4:00 PM
3.690
-0.040 (-1.07%)
After-hours: Sep 5, 2025, 8:00 PM EDT

Company Description

NovaBay Pharmaceuticals, Inc. does not have significant operations.

Previously, the company was engaged in the development and sale of eyecare, wound care, and skin care products in the United States and internationally.

The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007.

NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals logo
CountryUnited States
Founded2000
IPO DateOct 26, 2007
IndustryBiotechnology
SectorHealthcare
Employees14
CEOJustin Hall

Contact Details

Address:
2000 Powell Street, Suite 1150, eleventh floor
Emeryville, California 94608
United States
Phone510 899 8800
Websitenovabay.com

Stock Details

Ticker SymbolNBY
ExchangeNYSEAMERICAN
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001389545
CUSIP Number66987P201
ISIN NumberUS66987P4090
Employer ID68-0454536
SIC Code2834

Key Executives

NamePosition
Justin M. Hall Esq., J.D.President, Chief Executive Officer, General Counsel, Chief Compliance Officer, Corporate Secretary and Director
Tommy LawController, Interim Chief Financial Officer and Treasurer

Latest SEC Filings

DateTypeTitle
Sep 4, 2025SCHEDULE 13D/AFiling
Aug 26, 2025SCHEDULE 13DFiling
Aug 26, 20258-KCurrent Report
Aug 19, 20258-KCurrent Report
Aug 14, 202510-QQuarterly Report
Jun 4, 2025SCHEDULE 13DFiling
May 15, 202510-QQuarterly Report
May 15, 2025SCHEDULE 13G/AFiling
Apr 22, 20258-KCurrent Report
Apr 2, 202510-KAnnual Report
View All SEC Filings